Omnia Family Wealth, LLC Halozyme Therapeutics, Inc. Transaction History

Omnia Family Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$14.75 - $17.26 $16,874 - $19,745	-1,144 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $9,274 - $10,235	-556 Reduced 32.71%	1,144 $21,000
Q2 2018 Aug 10, 2018	BUY	$16.87 - $20.3 $28,679 - $34,510	1,700 New	1,700 $29,000
Q4 2017 Feb 02, 2018	SELL	$16.75 - $20.8 $5,025 - $6,240	-300 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $3,528 - $5,220	300	300 $5,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Omnia Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Omnia Family Wealth, LLC with notifications on news.